2013
Use of a Computerized Order Set to Increase Prescription of Calcium and Vitamin D Supplementation in Patients Receiving Glucocorticoids
Kohler MJ, Amezaga M, Drozd J, Crowley ST, Gulanski B, Anderson DR, Fraenkel L. Use of a Computerized Order Set to Increase Prescription of Calcium and Vitamin D Supplementation in Patients Receiving Glucocorticoids. Journal Of General Internal Medicine 2013, 28: 825-829. PMID: 23404201, PMCID: PMC3663954, DOI: 10.1007/s11606-013-2360-1.Peer-Reviewed Original ResearchConceptsVitamin D supplementationD supplementationVitamin DGlucocorticoid prescriptionComputerized ordersSingle VA medical centerOrder setsPrescription of calciumVitamin D prescriptionVitamin D supplementsGlucocorticoid-induced osteopeniaNumber of patientsKey ResultsA totalNumber of prescriptionsVA Medical CenterBackgroundAmerican CollegeGlucocorticoid useRheumatology guidelinesD supplementsResultsA totalMain MeasuresWeNumber of calciumPatientsA totalMedical CenterPatients
2011
Increased Risk of Fragility Fractures among HIV Infected Compared to Uninfected Male Veterans
Womack JA, Goulet JL, Gibert C, Brandt C, Chang CC, Gulanski B, Fraenkel L, Mattocks K, Rimland D, Rodriguez-Barradas MC, Tate J, Yin MT, Justice AC, . Increased Risk of Fragility Fractures among HIV Infected Compared to Uninfected Male Veterans. PLOS ONE 2011, 6: e17217. PMID: 21359191, PMCID: PMC3040233, DOI: 10.1371/journal.pone.0017217.Peer-Reviewed Original ResearchConceptsBody mass indexHIV infectionUninfected menFragility fracturesFracture riskRisk factorsMale veteransVeterans Aging Cohort Study Virtual CohortCurrent protease inhibitor useFragility fracture risk factorsMedian body mass indexHIV-specific factorsAdjusted hazard ratioProtease inhibitor useFracture risk factorsFragility fracture riskIncident hipHazard ratioInhibitor useUnadjusted riskHIV statusMass indexAlcohol abuseHIVUpper arm
2006
Preference for hip protectors among older adults at high risk for osteoporotic fractures.
Fraenkel L, Gulanski B, Wittink DR. Preference for hip protectors among older adults at high risk for osteoporotic fractures. The Journal Of Rheumatology 2006, 33: 2064-8. PMID: 17014021, PMCID: PMC1615711.Peer-Reviewed Original ResearchConceptsWeekly oral bisphosphonatesHip protectorsHigh riskOral bisphosphonatesHip fractureTreatment preferencesHealth problemsOlder adultsCommunity-dwelling older adultsCurrent bisphosphonate usersNonpharmacologic treatment approachesOsteoporotic hip fracturesMost health problemsType of treatmentBisphosphonate usersWeekly bisphosphonatesOsteoporotic fracturesFuture trialsDiscrete choice questionnaireTreatment choiceTreatment approachesBisphosphonatesStudy 57Absolute reductionPrescription drugsPatient treatment preferences for osteoporosis
Fraenkel L, Gulanski B, Wittink D. Patient treatment preferences for osteoporosis. Arthritis & Rheumatism 2006, 55: 729-735. PMID: 17013870, PMCID: PMC1626097, DOI: 10.1002/art.22229.Peer-Reviewed Original ResearchMeSH KeywordsAdministration, OralAgedAged, 80 and overBone Density Conservation AgentsCross-Sectional StudiesDiphosphonatesDose-Response Relationship, DrugFemaleFractures, BoneHealth Care SurveysHumansInfusions, IntravenousInjections, SubcutaneousMaleMiddle AgedOsteoporosisParathyroid HormonePatient CompliancePatient SatisfactionRecombinant ProteinsRisk AssessmentSurveys and QuestionnairesConceptsPreferred treatment optionRoute of administrationPatient's preferred treatment optionRecombinant human parathyroid hormoneOsteoporosis treatment optionsTreatment optionsAnnual infusionPatient preferencesTreatment preferencesIntravenous bisphosphonatesTreatment choiceRisk of vertebralTreatment-naive participantsPatients' treatment preferencesLong-term adherenceIndividual patient preferencesHuman parathyroid hormoneOral bisphosphonatesOsteoporosis medicationsWeekly bisphosphonatesWeekly pillConjoint analysis questionnaireOral medicationsHip fractureFuture fractures